Profitability
This table compares Defiance Daily Target 2X Long LMND ETF and Titan Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Defiance Daily Target 2X Long LMND ETF | 5.39% | 4.66% | 2.91% |
| Titan Medical | N/A | -82.31% | -51.47% |
Valuation and Earnings
This table compares Defiance Daily Target 2X Long LMND ETF and Titan Medical”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Defiance Daily Target 2X Long LMND ETF | $437.66 million | 0.01 | $15.17 million | $0.51 | 23.75 |
| Titan Medical | $17.63 million | 1.73 | $6.95 million | $0.05 | 5.36 |
Volatility and Risk
Defiance Daily Target 2X Long LMND ETF has a beta of -10.46, suggesting that its share price is 1,146% less volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500.
Insider & Institutional Ownership
87.8% of Defiance Daily Target 2X Long LMND ETF shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 6.6% of Defiance Daily Target 2X Long LMND ETF shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Defiance Daily Target 2X Long LMND ETF beats Titan Medical on 9 of the 11 factors compared between the two stocks.
About Defiance Daily Target 2X Long LMND ETF
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays. The company also provides xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism; ARIES system, a sample to answer real-time PCR platform; SYNCT data management software solutions; and ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 Assay, ARIES Flu A/B & RSV Assay, ARIES Group B Streptococcus Assay, ARIES Group A Strep Assay, ARIES Bordetella Assay, ARIES Norovirus Assay, ARIES C. difficile Assay, ARIES MRSA Assay, and SARS-CoV-2 Assay. In addition, it offers VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; VERIGENE test cartridges; Amnis FlowSight imaging flow cytometers; Amnis ImageStream Mark II imaging flow cytometers; Amnis CellStream for cell and particle analysis; Guava easyCyte benchtop flow cytometers; Muse cell analyzers; and IDEAS, an image analysis software. Luminex Corporation was founded in 1995 and is based in Austin, Texas.
About Titan Medical
Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.
Receive News & Ratings for Defiance Daily Target 2X Long LMND ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Defiance Daily Target 2X Long LMND ETF and related companies with MarketBeat.com's FREE daily email newsletter.
